NM23 gene expression in human prostatic carcinomas and benign prostatic hyperplasias: Altered expression in combined androgen blockaded carcinomas

Journal of Urology

Volumn 155, Issue 6, 1996, Pages 2080-2084

  Borchers, Holger ^b   Meyers, Frederick J ^b   Gumerlock, Paul H ^b   Stewart, Susan L ^b   Devere White, Ralph W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

biological; polymerase chain reaction; prostatic neoplasms; tumor markers

Indexed keywords

ANDROGEN; NM23 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER GRADING; CANCER STAGING; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METASTASIS POTENTIAL; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATE HYPERTROPHY; PROSTATECTOMY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE;

EID: 0029868797     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)66113-5     Document Type: Article

References (32)

1. Carter, H. B. and Coffey, D. S.: The prostate: an increasing problem. Prostate, 16: 39, 1990.
2. Steeg, P. S., Cohn, K. H. and Leone, A.: Tumor metastasis and nm23: current concepts. Cancer Cells, 3: 257, 1991.
3. Tokunaga, Y., Urano, T., Furukawa, K., Kondo, H., Kanematsu, T. and Shiku, H.: Reduced expression of nm23-H1, but not nm23-H2, is concordant with the frequency of lymph-node metastasis of human breast cancer. Int. J. Cancer, 55: 66, 1993.
4. Hennessy, C., Henry, J. A., May, F. E. B., Westley, B. R., Angus, B. and Lennard, T. W. J.: Expression of the antimetastatic gene nm23 in human breast cancer: an association with good prognosis. J. Natl. Cancer Inst., 83: 281, 1991.
5. Fishman, J. R., Gumerlock, P. H., Meyers, F. J. and deVere White, R. W.: Quantitation of NM23 expression in human prostate tissues. J. Urol., 152: 202, 1994.
6. Konishi, N., Nakaoka, S., Tsuzuki, T., Matsumoto, K., Kitahori, Y., Hiasa, Y., Urano, T. and Shiku, H.: Expression of nm23-H1 and nm23-H2 proteins in prostate carcinoma. Jpn. J. Cancer Res., 84: 1050, 1993.
7. Igawa, M., Rukstalis, D. B., Tanabe, T. and Chodak, G. W.: High levels of nm23 expression are related to cell proliferation in human prostate cancer. Cancer Res., 54: 1313, 1994.
8. Gumerlock, P. H., Poonamallee, U. R., Meyers, F. J. and deVere White, R. W.: Activated ras alleles in human carcinoma of the prostate are rare. Cancer Res., 51: 1632, 1991.
9. Stone, K. R., Mickey, D. D., Wunderli, H., Mickey, G. H. and Paulson, D. F.: Isolation of a human prostate carcinoma cell line (DU-145). Int. J. Cancer, 21: 274, 1978.
10. Horoszewicz, J. S., Leong, S. S., Kawinski, E., Karr, J. P., Rosenthal, H., Chu, T. M., Mirand, E. A. and Murphy, G. P.: LNCaP model of human prostatic carcinoma. Cancer Res., 43: 1809, 1983.
11. Meyers, F. J., Gumerlock, P. H., Kawasaki, E. S., Wang, A. M., deVere White, R. W. and Ehrlich, H. A.: Bladder cancer: human leukocyte antigen II, interleukin-6, and interleukin-6 receptor expression determined by the polymerase chain reaction. Cancer, 67: 2087, 1991.
12. Stahl, J. A., Leone, A., Rosengard, A. M., Porter, L., King, C. R. and Steeg, P. S.: Identification of a second human nm23 gene, nm23-H2. Cancer Res., 51: 445, 1991.
13. Madewell, B. R., Gumerlock, P. H., Saunders, K. A., Meyers, F. J., Kraegel, S. A. and Kawasaki, E. S.: Canine and bovine ras family expression detected and discriminated by the use of polymerase chain reaction. Anticancer Res., 9: 1743, 1989.
14. Gumerlock, P. H., Tang, Y. J., Meyers, F. J. and Silva, J., Jr.: Use of the polymerase chain reaction for the specific and direct detection of Clostridium difficile in human feces. Rev. Infect. Dis., 13: 1053, 1991.
15. Lehmann, E. L.: Nonparametrics. San Francisco: Holden-Day, 1975.
16. Gilles, A. M., Presecan, E., Vonica, A. and Lascu, I.: Nucleoside diphosphate kinase from human erythrocytes: structural characterization of the two polypeptide chains responsible for heterogenity of the hexameric enzyme. J. Biol. Chem., 266: 8784, 1991.
17. Steeg, P. S., Bevilacqua, G., Kopper, L., Thorgeirsson, U. P., Talmagde, J. E., Liotta, L. A. and Sobel, M. E.: Evidence for a novel gene associated with low tumor metastatic potential. J. Natl. Cancer Inst., 80: 200, 1988.
18. Steeg, P. S., Bevilacqua, G., Pozzatti, R., Liotta, L. A. and Sobel, M. E.: Altered expression of nm23, a gene associated with low metastatic potential, during adenovirus 2 Ela inhibition of experimental metastasis. Cancer Res., 48: 6550, 1988.
19. Leone, A., Seeger, R. C., Hong, C. M., Hu, Y. Y., Arboleda, M. J., Brodeur, G. M., Strain, D., Slamon, D. J. and Steeg, P. S.: Evidence for nm23 RNA overexpression, DNA amplification and mutation in aggressive childhood neuroblastomas. Oncogene, 8: 855, 1993.
20. Sastre-Garau, X., Lacombe, M. L., Jouve, M., Veron, M. and Magdelenat, H.: Nucleoside diphosphate kinase/nm23 expression in breast cancer: lack of correlation with lymph-node metastasis. Int. J. Cancer, 50: 533, 1992.
21. Haut, M., Steeg, P. S., Willson, J. K. V. and Markowitz, S. D.: Induction of nm23 gene expression in human colonic neoplasms and equal expression in colon tumors of high and low metastatic potential. J. Natl. Cancer Inst., 83: 712, 1991.
22. Nakamori, S., Ishikawa, O., Ohhigashi, H., Kameyama, M., Furukawa, H., Sasaki, Y., Inaji, H., Higashiyama, M., Imaoka, S., Iwanaga, T., Funai, H., Wada, A. and Kimura, N.: Eypression of nucleoside diphosphate kinase/nm23 gene product in human pancreatic cancer: an association with lymph node metastasis and tumor invasion. Clin. Exp. Metastasis, 11: 151, 1993.
23. Hailat, N., Keim, D. R., Melhem, R. F., Zhu, X.-X., Eckerkorn, C., Brodeur, G. M., Reynolds, C. P., Seeger, R. C., Lottspeich, F., Strahler, J. R. and Hanash, S. M.: High levels of p19/nm23 protein in neuroblastoma are associated with advanced stage disease and with N-myc gene amplification. J. Clin. Invest., 88: 341, 1991.
24. Lacombe, M. L., Sastre-Garau, X., Lascu, I., Vonica, A., Wallet, V., Thiery, J. P. and Veron, M.: Overexpression of nucleoside diphosphate kinase (Nm23) in solid tumors. Eur. J. Cancer, 27: 1302, 1991.
25. Wang, L., Patel, U., Ghosh, L., Chen, H.-C. and Banerjee, S.: Mutation in the nm23 gene is associated with metastasis in colorectal cancer. Cancer Res., 53: 717, 1993.
26. Chang, C. L., Zhu, X.-X., Thorayel, D. H., Ungar, D., Rawwas, J., Hora, N., Strahler, J. R., Hanash, S. M. and Radany, E.: nm23-H1 mutation in neuroblastoma. Nature, 370: 335, 1994.
27. Postel, E. H., Berberich, S. J., Flint, S. J. and Ferrone, C. A.: Human c-myc transcription factor PuF identified as nm23-H2 nucleoside diphosphate kinase, a candidate suppressor of tumor metastasis. Science, 261: 478, 1993.
28. Colombel, M., Olsson, C. A., Ng, P.-Y. and Buttyan, R.: Hormone-regulated apoptosis results from reentry of differentiated prostate cells onto a defective cell cycle. Cancer Res., 52: 4313, 1992.
29. Tenniswood, M. P., Guenette, S., Lakins, J., Mooibroek, M., Wong, P. and Welsh, J.-E.: Active cell death in hormone-dependent tissues. Cancer Metastasis Rev., 11: 197, 1992.
30. Lee, C. and Sensibar, J. A.: Proteins of the rat prostate. II. Synthesis of new proteins in the ventral lobe during castration induced regression. J. Urol., 138: 903, 1987.
31. Sensibar, J. A., Alger, B., Tseng, A., Berg, L. and Lee, C.: Proteins of the rat prostate. III. Effect of testosterone on protein synthesis by the ventral prostate of castrated rats. J. Urol., 143: 161, 1990.
32. Leger, J. G., Montpetit, M. L. and Tenniswood, M. P.: Characterization and cloning of androgen-repressed mRNAs from rat ventral prostate. Biochem. Biophys. Res. Commun., 147: 196, 1987.